Benjamin Cowling
Study Compares Pfizer-BioNTech and Sinovac Vaccines
People who receive a COVID vaccine from Pfizer-BioNTech produce 10 times more antibodies than those who opted for Sinovac's CoronaVac, a Chinese drug. This was reported on Friday, July 16 by South China Morning Post with reference to relevant research.